Skip to main content

Featured

Global Travel Industry Reels as Middle East Conflict Triggers Deep Market Shock

Stranded passengers wait near Emirates Airways customer service office at I Gusti Ngurah Rai International Airport in Kuta, Bali, Indonesia. Travel stocks have plunged sharply as the escalating conflict involving the US, Israel, and Iran triggers the most severe disruption to global aviation since the pandemic. Major Middle Eastern hubs—including Dubai, the world’s busiest international airport—have remained closed for days, stranding tens of thousands of passengers and forcing airlines to reroute or cancel flights on a massive scale.  Oil prices have surged by about 7% amid rising geopolitical tensions, adding further pressure to airlines already grappling with operational chaos. Higher fuel costs are expected to squeeze margins across the sector, with analysts warning that the ripple effects could last for weeks.  European travel giants have been hit especially hard. Shares in TUI dropped 8.5% in early trading, while Lufthansa and other major carriers saw declines of up t...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment